Furthermore, high level of HK2 is significantly associated with some phenotypes of tumor aggressiveness, such as large tumor size, positive lymph node metastasis and advanced clinical stage [6,7], while down-regulation of HK2 expression resulted in better efficacy of anti-cancer drugs [8,9] and promotes tumor radiosensitization [10,11]. This evidence concerns the gene HK2 and cancer.